Vanguard Total Stock Market ETF (VTI)

Richtech Robotics has partnered with Microsoft, and both companies have worked to upgrade Richtech’s ADAM robot using Azure AI technologies.

The company tied up with Davidson Technologies and defense company Anduril Industries to develop quantum-classical hybrid applications for U.S. air and missile defense scenarios.

Brand Engagement Network shot into the retail spotlight after announcing an AI licensing partnership deal in South Africa last week.

This fund is a perfect example of buying the haystack instead of seeking the needle.

Battalion has entered into a gas treating agreement with a publicly traded large-cap midstream company, bringing the stock under retail traders’ radar.

According to Bate’s Linkedin, he is now plant manager at Redwood-city-based electric thermal management and sensing solutions provider Chemelex.

The chip brings increased memory, data flow, and compute capabilities to Microsoft’s cloud infrastructure and aids the company’s push to support advanced AI workloads.

The U.S. stock market is experiencing a big rotation in 2026 that's been great for small caps and cyclicals, but not so much for tech. That makes this Vanguard ETF an ideal pick-up in the new year.

Previously, Tesla offered basic autopilot as a standard on new vehicle purchases, which included autosteer and traffic-aware cruise control.

First Trust Low Duration Opportunities ETF targets short-term bonds, providing a steady yield for investors seeking income stability.

UBS cited developments in Microsoft’s AI infrastructure deployments as a key driver of future cloud expansion.

If you want to build a million-dollar investment portfolio, you don't need to do anything extraordinary.

Tesla FSD is yet to enable fully autonomous driving and requires active driver supervision.

The top voted question for Tesla leadership pertains to whether Tesla shareholders will be prioritized in the event of a SpaceX IPO.

Chip Wilson alleged on Wednesday that the company has “completely lost its way” as a technical apparel leader and that it has failed to deliver products that “work.”

As per a report from Bloomberg News, Eaton is working with an adviser to explore a sale or spinoff of the unit.

CEPI will provide Merck with $30 million and Merck will, in turn, leverage its joint venture with Wellcome, called Hilleman Laboratories, to develop an Ebola vaccine with an updated manufacturing process.

Lisata said that it has entered into a binding term sheet under which the two companies agreed to negotiate in good faith and enter into a customary purchase agreement.

The company’s subsidiary, Lucid Diagnostics, secured a contract from the U.S. Department of Veterans Affairs to provide its EsoGuard Esophageal DNA Test for the detection of esophageal precancer.

LightPath said it has acquired the assets of Amorphous Materials for an aggregate consideration of $7.0 million in cash with potential additional milestone-based equity consideration of up to $3 million.